In today's video-driven world, standing out is more important than ever. From battling a saturated market to adapting to privacy-friendly targeting standards, advertisers are challenged to break through the noise while connecting with audiences in impactful ways.
The key lies in a strategic combination of high-impact video content tailored to audiences’ consumption preferences and Nativo’s proprietary, privacy-compliant technology, SPARC, powered by Nativo Predictive Audiences, which finds & delivers the optimal content, format, and audience mix.
Read on to discover which of Nativo's video formats may be the right fit to pair with SPARC for your next video campaign!
Nativo’s Large Video Format offers a premium, large video player designed to broaden brand awareness and expand video reach across top editorial content.
Benefits:
Use Cases:
Native Video is an in-feed, non-incentivized video placement that matches the look and feel of publisher content, driving qualified video views from engaged consumers.
Benefits:
Use Cases:
Stories is a high impact content-based format that inspires engagement with an immersive experience designed for today’s consumer. Scale content outside of social media with the ability to use existing stories (Instagram, Tik Tok, etc.) assets while maintaining superior control over brand safety and contextual relevance.
Benefits:
Use Cases:
Whether you wish to maintain control with a prescriptive video mix or want to opt for a run-of-network package optimized by SPARC, we have you covered!
Retail TouchPoints | Why leading with value, trust and consumer-first solutions matters this BTS season
Read More
How to Plan Back-to-School Campaigns in a Tense Economic Environment
AdExchanger | In a world where AI agents are the new gatekeepers, content marketing is not just a brand builder.
Read More
Marketing To Machines: A New Performance Strategy In The Age Of AI Agents
Pharma advertisers are facing a fundamental challenge: justify value at every impression.
Read More
Part 2: Advertising in the Age of Accountability — Navigating Pharma’s New Media Mandate